X0306
4
2021-12-29
0
0000081362
QUAKER CHEMICAL CORP
KWR
0001238141
BARRY MICHAEL F
8001 TWIN EAGLES LOOP
REUNION
FL
34747
1
0
0
0
Common Stock
2021-12-29
4
S
0
2973
230.4449
D
84376
D
Common Stock
2021-12-29
4
S
0
1294
231.2692
D
83082
D
Common Stock
2021-12-29
4
S
0
2289
232.2745
D
80793
D
Common Stock
2021-12-29
4
S
0
101
233.2247
D
80692
D
Common Stock
2021-12-30
4
S
0
277
229.5387
D
80415
D
Common Stock
2021-12-30
4
S
0
1950
230.5652
D
78465
D
Common Stock
2021-12-30
4
S
0
2044
231.5851
D
76421
D
Common Stock
2021-12-30
4
S
0
979
232.2023
D
75442
D
Common Stock
2021-12-31
4
S
0
2356
230.8897
D
73086
D
Common Stock
2021-12-31
4
S
0
737
231.6171
D
72349
D
Common Stock
2022-01-01
4
A
0
198
0.00
A
72547
D
Common Stock
34973
I
By 401(k)
The sale of shares reported for this transaction was effected pursuant to a Rule 10b5-1 Plan entered into by reporting person on November 24, 2021.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $229.91 to $230.88, inclusive. The reporting person undertakes to provide to Quaker Chemical Corporation, d/b/a "Quaker Houghton", any security holder of Quaker Houghton, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $230.92 to $231.89, inclusive. The reporting person undertakes to provide to Quaker Chemical Corporation, d/b/a "Quaker Houghton", any security holder of Quaker Houghton, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (3) to this Form 4.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $231.98 to $232.81, inclusive. The reporting person undertakes to provide to Quaker Chemical Corporation, d/b/a "Quaker Houghton", any security holder of Quaker Houghton, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (4) to this Form 4.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $233.22 to $233.69, inclusive. The reporting person undertakes to provide to Quaker Chemical Corporation, d/b/a "Quaker Houghton", any security holder of Quaker Houghton, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (5) to this Form 4.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $228.92 to $229.89, inclusive. The reporting person undertakes to provide to Quaker Chemical Corporation, d/b/a "Quaker Houghton", any security holder of Quaker Houghton, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (6) to this Form 4.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $230.00 to $230.95, inclusive. The reporting person undertakes to provide to Quaker Chemical Corporation, d/b/a "Quaker Houghton", any security holder of Quaker Houghton, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (7) to this Form 4.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $231.05 to $232.04, inclusive. The reporting person undertakes to provide to Quaker Chemical Corporation, d/b/a "Quaker Houghton", any security holder of Quaker Houghton, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (8) to this Form 4.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $232.06 to $232.49, inclusive. The reporting person undertakes to provide to Quaker Chemical Corporation, d/b/a "Quaker Houghton", any security holder of Quaker Houghton, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (9) to this Form 4.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $230.21 to $231.19, inclusive. The reporting person undertakes to provide to Quaker Chemical Corporation, d/b/a "Quaker Houghton", any security holder of Quaker Houghton, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (10) to this Form 4.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $231.21 to $232.00, inclusive. The reporting person undertakes to provide to Quaker Chemical Corporation, d/b/a "Quaker Houghton", any security holder of Quaker Houghton, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (11) to this Form 4.
Time-based restricted stock award granted to Quaker Houghton's non-management director as prorated portion of annual retainer paid to Directors.
Information based on reporting person's Plan Statement as of September 30, 2021.
Victoria K. Gehris, Attorney-in-Fact for Michael F. Barry
2022-01-03